相关实验视频
Updated: Jul 10, 2025

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.0K
一个快速而非侵入性的人工智能嗅觉系统,有助于诊断帕金森病
Yina Cao1, Lina Jiang2, Jingxin Zhang1
1Department of Neurology, The Fourth Affiliated Hospital of Zhejiang University Medical College, Zhejiang, China.
European journal of neurology
|November 27, 2023
概括
这项研究开发了一种便携式AI嗅觉系统,用于分析皮肤挥发性有机化合物 (VOCs),用于帕金森病 (PD) 诊断. 该系统准确地将PD患者与对照患者区分开来,提供一种非侵入性诊断工具.
科学领域:
- 神经退行性疾病诊断神经退行性疾病诊断
- 使用挥发性有机化合物 (VOCs) 发现生物标志物.
- 医疗保健中的人工智能
背景情况:
- 以前的研究表明,皮肤脂质分析可以帮助诊断帕金森病 (PD).
- 皮脂中的挥发性有机化合物 (VOC) 是PD的潜在生物标志物.
研究的目的:
- 开发一个便携式的人工智能嗅觉类似 (AIO) 系统用于PD诊断.
- 用气色谱和人工智能分析皮肤VOCs.
- 探索AIO系统对PD的诊断价值.
主要方法:
- 使用AIO系统分析了121名PD患者和129名健康对照者的皮肤VOCs.
- 开发并比较了三个机器学习模型:渐变增强决策树 (GBDT),随机森林和极端渐变增强.
- 从AIO系统收集了每个参与者的20秒时间序列数据.
主要成果:
- 在PD受试者中,在5-12秒之间观察到明显更高的VOC峰值.
- GBDT模型实现了最高的诊断性能,灵敏度为83.33%,特异性为84.00%.
- 该系统无法根据Hoehn-Yahr阶段预测PD的进展.
结论:
- 该AIO系统提供了一种快速,低成本和非侵入性的方法来区分PD患者和健康个体.
- 这些发现表明PD患者的脂质腺分泌异常.
- 为调查帕金森病的发病因子提供了新的证据.
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557

